Aug 21, 2022
A born entrepreneur and self-made man, Todd Ault wields his expertise in a massive range of financial markets, from real estate to private equity to commodities. His diverse and unique companies prove that there is no venture he has not conquered.
Todd is committed to sharing his experience, insights, and expansive knowledge through media, writing, coaching, and speaking.
Todd also has an unshakable determination. That drive landed him a successful 30 plus year career on Wall Street. That might have been enough for some, but bigger aspirations called, so he began to buy and found companies that would eventually sell…for hundreds of millions of dollars.
Todd’s specialty is acquiring undervalued assets and disruptive technologies that have major global impact. As the Founder of Bitnile Holdings (listed on the NYSE American: NILE), Todd’s companies span a myriad of industries, including cryptocurrencies, digital manufacturing technology, defense and aerospace, biotech, hospitality, corporate lending, and real estate.
One of Todd’s greatest accomplishments is founding the start-up biotech company, Alzamend Neuro (NASDAQ: ALZN), that seeks to bring preventions, treatments, and cures for Alzheimer’s disease “out of the laboratory and into people’s lives.” Alzamend’s first drug (AL001) is in early human clinical testing, and is expecting their second drug, (AL002), to be testing in 2022.
Enjoy this engaging and informative conversation as Todd connects with Lou Diamond on Thrive LouD.